18F-AV-1451 Autopsy Study

• Status: Completed
• Trial end date: 2018-07-15

Summary

This study is designed to test the relationship between ante-mortem flortaucipir Positron Emission Tomography (PET) imaging and tau neurofibrillary pathology associated with Alzheimer's disease (AD), as measured at autopsy.

• Phase: Phase 3

Details

• Lead Sponsor: Avid Radiopharmaceuticals